Nisa Investment Advisors, LLC Alaunos Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$2.09 - $3.09 $4,556 - $6,736	-2,180 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$1.9 - $4.98 $1,938 - $5,079	1,020 Added 87.93%	2,180 $5,000
Q3 2018 Oct 16, 2018	SELL	$2.26 - $3.27 $745 - $1,079	-330 Reduced 22.15%	1,160 $4,000
Q3 2017 Oct 13, 2017	BUY	$4.99 - $6.57 $7,435 - $9,789	1,490	1,490 $9,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.